Skip to main content

Optimization for production of exopolysaccharides with antitumor activity in vitro from Paecilomyces hepiali.

  • 2014-01
  • Carbohydrate Polymers 99
    • Zhongwei Wu
    • Junwen Lu
    • Xiaoqing Wang
    • Bing Hu
    • Hong Ye
    • Jia-Qin Fan
    • Muhammad Abid
    • Xiaoxiong Zeng

Abstract

In the present study, optimal medium for the growth of mycelia and the production of exopolysaccharides from Paecilomyces hepiali HN1 (PHEPS) in submerged culture was investigated. As a result, the maximum production of mycelia (12.98 ± 0.14 g/L) and PHEPS (5.33 ± 0.11 g/L) were achieved under the optimal medium of sucrose 46.08 g/L, yeast extract 4.71 g/L, (NH₄)₂SO₄ 5.72 g/L, KH₂PO₄ 1.70 g/L, CaCl₂ 0.50 g/L, MgSO₄ 0.50 g/L, potato extract 1% and malt extract 1%. Furthermore, the antitumor activity of PHEPS in vitro was evaluated by using three cell lines of human liver tumor HepG2 cells, breast cancer MCF-7 cells and cervical cancer Hela cells. It was found that PHEPS exhibited relative higher anti-proliferative activity against HepG2 cells than MCF-7 cells and Hela cells. At a concentration of 500 μg/mL and 72 h treatment, the inhibition rate of PHEPS on HepG2 cells reached to 62.58%. All these results suggested that PHEPS could be explored as novel natural antitumor agent with great potential application.

Keywords: Antitumor activity; Optimization; Paecilomyces hepiali HN1; Polysaccharides.

Research Insights

SupplementHealth OutcomeEffect TypeEffect Size
Paecilomyces hepialiIncreased Anticancer ActivityBeneficial
Large
⬆ Back to top
Pillser
Supplement Research and Comparison Website: evidence-based information about supplements, their benefits, potential risks, and their efficacy.
Receive updates about our products, services, sales, and special offers. Unsubscribe anytime. See our Privacy Policy for details on how we handle your information.

Join Our Community

Use support@pillser.com to get in touch.